Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Seefeld, Mark A
Miller, William H
Newlander, Kenneth A
Burgess, Walter J
Payne, David J
Rittenhouse, Stephen F
Moore, Terrance D
DeWolf, Walter E
Keller, Paul M
Qiu, Xiayang
Janson, Cheryl A
Vaidya, Kalindi
Fosberry, Andrew P
Smyth, Martin G
Jaworski, Deborah D
Slater-Radosti, Courtney
and
Huffman, William F
2001.
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
Bioorganic & Medicinal Chemistry Letters,
Vol. 11,
Issue. 17,
p.
2241.
McDevitt, Damien
and
Rosenberg, Martin
2001.
Exploiting genomics to discover new antibiotics.
Trends in Microbiology,
Vol. 9,
Issue. 12,
p.
611.
Heath, Richard J.
White, Stephen W.
and
Rock, Charles O.
2001.
Lipid biosynthesis as a target for antibacterial agents.
Progress in Lipid Research,
Vol. 40,
Issue. 6,
p.
467.
Campbell, John W.
and
Cronan, John E.
2001.
Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery.
Annual Review of Microbiology,
Vol. 55,
Issue. 1,
p.
305.
Khandekar, Sanjay S.
Gentry, Daniel R.
Van Aller, Glenn S.
Warren, Patrick
Xiang, Hong
Silverman, Carol
Doyle, Michael L.
Chambers, Pamela A.
Konstantinidis, Alex K.
Brandt, Martin
Daines, Robert A.
and
Lonsdale, John T.
2001.
Identification, Substrate Specificity, and Inhibition of theStreptococcus pneumoniae β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH).
Journal of Biological Chemistry,
Vol. 276,
Issue. 32,
p.
30024.
Qiu, Xiayang
Janson, Cheryl A
Smith, Ward W
Head, Martha
Lonsdale, John
and
Konstantinidis, Alex K
2001.
Refined structures of β-ketoacyl-acyl carrier protein synthase III.
Journal of Molecular Biology,
Vol. 307,
Issue. 1,
p.
341.
Villalaín, José
Mateo, C.Reyes
Aranda, Francisco J.
Shapiro, Stuart
and
Micol, Vicente
2001.
Membranotropic Effects of the Antibacterial Agent Triclosan.
Archives of Biochemistry and Biophysics,
Vol. 390,
Issue. 1,
p.
128.
Payne, David J
Warren, Patrick V
Holmes, David J
Ji, Yinduo
and
Lonsdale, John T
2001.
Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery.
Drug Discovery Today,
Vol. 6,
Issue. 10,
p.
537.
Heerding, Dirk A
Chan, George
DeWolf, Walter E
Fosberry, Andrew P
Janson, Cheryl A
Jaworski, Deborah D
McManus, Edward
Miller, William H
Moore, Terrance D
Payne, David J
Qiu, Xiayang
Rittenhouse, Stephen F
Slater-Radosti, Courtney
Smith, Ward
Takata, Dennis T
Vaidya, Kalindi S
Yuan, Catherine C.K
and
Huffman, William F
2001.
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI).
Bioorganic & Medicinal Chemistry Letters,
Vol. 11,
Issue. 16,
p.
2061.
Marcinkeviciene, Jovita
Jiang, Wenjun
Kopcho, Lisa M
Locke, Gregory
Luo, Ying
and
Copeland, Robert A
2001.
Enoyl-ACP Reductase (FabI) of Haemophilus influenzae: Steady-State Kinetic Mechanism and Inhibition by Triclosan and Hexachlorophene.
Archives of Biochemistry and Biophysics,
Vol. 390,
Issue. 1,
p.
101.
Perozzo, Remo
Kuo, Mack
Sidhu, Amar bir Singh
Valiyaveettil, Jacob T.
Bittman, Robert
Jacobs, William R.
Fidock, David A.
and
Sacchettini, James C.
2002.
Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan for Malarial Enoyl Acyl Carrier Protein Reductase.
Journal of Biological Chemistry,
Vol. 277,
Issue. 15,
p.
13106.
Kuo, Mack R.
Morbidoni, Hector R.
Alland, David
Sneddon, Scott F.
Gourlie, Brian B.
Staveski, Mark M.
Leonard, Marina
Gregory, Jill S.
Janjigian, Andrew D.
Yee, Christopher
Musser, James M.
Kreiswirth, Barry
Iwamoto, Hiroyuki
Perozzo, Remo
Jacobs, William R.
Sacchettini, James C.
and
Fidock, David A.
2003.
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase.
Journal of Biological Chemistry,
Vol. 278,
Issue. 23,
p.
20851.
Wright, H.Tonie
2004.
Cofactors in Fatty Acid Biosynthesis—Active Site Organizers and Drug Targets.
Structure,
Vol. 12,
Issue. 3,
p.
358.
Pidugu, Lakshmi Swarnamukhi
Kapoor, Mili
Surolia, Namita
Surolia, Avadhesha
and
Suguna, Kaza
2004.
Structural Basis for the Variation in Triclosan Affinity to Enoyl Reductases.
Journal of Molecular Biology,
Vol. 343,
Issue. 1,
p.
147.
Qiu, Xiayang
Choudhry, Anthony E.
Janson, Cheryl A.
Grooms, Michael
Daines, Robert A.
Lonsdale, John T.
and
Khandekar, Sanjay S.
2005.
Crystal structure and substrate specificity of the β‐ketoacyl‐acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
Protein Science,
Vol. 14,
Issue. 8,
p.
2087.
Wickramasinghe, Sasala R.
Inglis, Kirstine A.
Urch, Jonathan E.
Müller, Sylke
van Aalten, Daan M. F.
and
Fairlamb, Alan H.
2006.
Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis.
Biochemical Journal,
Vol. 393,
Issue. 2,
p.
447.
Ashek, Ali
and
Cho, Seung Joo
2006.
A combined approach of docking and 3D QSAR study of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Bioorganic & Medicinal Chemistry,
Vol. 14,
Issue. 5,
p.
1474.
Rafi, Salma
Novichenok, Polina
Kolappan, Subramaniapillai
Zhang, Xujie
Stratton, Christopher F.
Rawat, Richa
Kisker, Caroline
Simmerling, Carlos
and
Tonge, Peter J.
2006.
Structure of Acyl Carrier Protein Bound to FabI, the FASII Enoyl Reductase from Escherichia coli.
Journal of Biological Chemistry,
Vol. 281,
Issue. 51,
p.
39285.
Lee, Hyung Ho
Moon, Jinho
and
Suh, Se Won
2007.
Crystal structure of the Helicobacter pylori enoyl‐acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan.
Proteins: Structure, Function, and Bioinformatics,
Vol. 69,
Issue. 3,
p.
691.
Janin, Yves L.
2007.
Antituberculosis drugs: Ten years of research.
Bioorganic & Medicinal Chemistry,
Vol. 15,
Issue. 7,
p.
2479.